Navigation Links
Sunpeaks Ventures Files Defamation Lawsuit
Date:5/1/2012

SILVER SPRING, Md., May 1, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (the "Company" or "Sunpeaks Ventures") announced today that is has filed a Complaint in the Circuit Court for Montgomery County, Maryland against Deal Flow Media, Inc., Thomas Siudak, Red Carpet Books, Inc., and Bill Martlink alleging that they engaged in a systematic series of false, defamatory, and malicious statements as part of a larger conspiracy in an attempt to cause harm to the Company.

"We said last week that we will not stand by idly and allow Sunpeaks to be victimized by persons making baseless and scurrilous comments about the Company.  Today, we are backing up that statement," stated Mackie A. Barch, CEO of Sunpeaks Ventures.  "And it is very possible that, as we continue to investigate, we will seek to hold accountable other participants."

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.  HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "es
'/>"/>

SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunpeaks Ventures to Exhibit Clotamin at the first-ever Thrombosis and Hemostasis Summit of North America
2. Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
3. Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries
4. Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies
5. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
6. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
7. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
8. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
9. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
10. Sunpeaks Ventures to Participate in ECRM Conference and Expo
11. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a ... and inoperable solid tumor cancers, announced today that CEO ... Annual Phacilitate Immunotherapy Forum in Washington D.C. ... place on January 26 at 10:30 a.m. EST at the ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has ... increase market share and grab a foothold in the hydroponic, ... production capabilities and a presence in the sector, and recently ... the growth of hemp and medical marijuana, iMD is committing ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... 7 Ardea,Biosciences, Inc. (Nasdaq: RDEA ) ... activity of the Company,s non-nucleoside reverse,transcriptase inhibitor (NNRTI) ... known causative agent of AIDS,including NNRTI-resistant strains., ... Conference on Retroviruses,and Opportunistic Infections (CROI) in Boston., ...
... gastrointestinal and lipid effects between ... N.J., Feb. 6 Bristol-Myers Squibb,Company (NYSE: ... study, in which,300 mg of once-daily REYATAZ(R) (atazanavir ... similar antiviral efficacy to twice-daily,lopinavir 400 mg and ...
Cached Medicine Technology:Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 2Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 3CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 2CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 3CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 4CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 5CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients 6
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... Thermage, Inc.,(Nasdaq: THRM ), announced today that ... and full year ended December 31, 2007, after the,market ... also host a,conference call and webcast on Tuesday, February ... to discuss the financial results and,current corporate developments. The ...
... The Bishop of Manchester,has made a series of serious ... researcher, inventor of the science of,Plastination, and creator of ... and at a Press Conference at Manchester Cathedral on ... WORLDS 4,exhibition, to be hosted by the Museum of ...
... It,s one thing to daydream about all,the free time ... to,seriously map out the steps you need to take ... Listen to this report from AXA Equitable (NYSE: ... access video, audio, text, graphics and,photos for free and ...
... study, a new technique helped patients retrieve long-lost details ... interviewing technique has drawn out extensive details hidden in ... researchers say. , There,s ongoing debate about whether long-term ... the medial temporal lobe, which contains the memory-processing center ...
... Record Annual Net Sales and Net Income, SALT LAKE ... a leading producer of advanced digital hearing aids,today announced results ... 2007 of $32.3 million were up 12.4% over the $28.7 ... year 2007 of $122.5,million improved 16.1% over the $105.5 million ...
... of $55.9 Million and Contract Value ... Growth of ... WASHINGTON, Feb. 5 The Advisory Board Company,(Nasdaq: ABCO ) ... March 31, 2008. Revenue for the quarter increased,15% to $55.9 million, from ...
Cached Medicine News:Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 2Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 3Health News:The Institute for Plastination Responds to the Bishop of Manchester's Media Blitz, Assertions, and Allegations About BODY WORLDS Anatomical Exhibition Coming to Manchester 4Health News:Brain Injury May Not Erase Long-Term Memory 2Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 2Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 3Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 4Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 5Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 6Health News:Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007 7Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 10Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 11Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 12Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 13Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 14Health News:The Advisory Board Company Reports Fiscal Year 2008 Third Quarter Results 15
Inquire...
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: